BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12938190)

  • 1. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.
    D'Costa J; Harvey-White J; Qasba P; Limaye A; Kaneski CR; Davis-Warren A; Brady RO; Bankiewicz KS; Major EO; Arya SK
    J Med Virol; 2003 Oct; 71(2):173-82. PubMed ID: 12938190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AAV vector-mediated gene transfer and its application to the nervous system].
    Ozawa K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):835-8. PubMed ID: 15152479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy for Parkinson's disease].
    Muramatsu S
    Brain Nerve; 2007 Apr; 59(4):425-30. PubMed ID: 17447529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for Parkinson's disease.
    Lawlor PA; During MJ
    Expert Rev Mol Med; 2004 Mar; 6(5):1-18. PubMed ID: 15000692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
    Fan D; Shen Y; Kang D; Nakano I; Ozawa K
    Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
    Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
    Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseases.
    Estruch EJ; Hart SL; Kinnon C; Winchester BG
    J Gene Med; 2001; 3(5):488-97. PubMed ID: 11601762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice.
    Jung SC; Han IP; Limaye A; Xu R; Gelderman MP; Zerfas P; Tirumalai K; Murray GJ; During MJ; Brady RO; Qasba P
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2676-81. PubMed ID: 11226298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells.
    Yoshimitsu M; Higuchi K; Ramsubir S; Nonaka T; Rasaiah VI; Siatskas C; Liang SB; Murray GJ; Brady RO; Medin JA
    Gene Ther; 2007 Feb; 14(3):256-65. PubMed ID: 16929352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preselective gene therapy for Fabry disease.
    Qin G; Takenaka T; Telsch K; Kelley L; Howard T; Levade T; Deans R; Howard BH; Malech HL; Brady RO; Medin JA
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3428-33. PubMed ID: 11248095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.
    During MJ; Samulski RJ; Elsworth JD; Kaplitt MG; Leone P; Xiao X; Li J; Freese A; Taylor JR; Roth RH; Sladek JR; O'Malley KL; Redmond DE
    Gene Ther; 1998 Jun; 5(6):820-7. PubMed ID: 9747462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy for Parkinson's disease: studies in animal models].
    Muramatsu S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.